Literature DB >> 16694463

DISTRIBUTION OF RESPIRATORY GASES IN A CLOSED BREATHING CIRCUIT. II. PULMONARY FIBROSIS AND EMPHYSEMA.

A Cournand1, H C Lassen, D W Richards.   

Abstract

Entities:  

Year:  1937        PMID： 16694463      PMCID： PMC424840          DOI： 10.1172/JCI100842

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  2 in total

1.  DISTRIBUTION OF RESPIRATORY GASES IN A CLOSED BREATHING CIRCUIT. I. IN NORMAL SUBJECTS.

Authors:  H C Lassen; A Cournand; D W Richards
Journal:  J Clin Invest       Date:  1937-01       Impact factor: 14.808

2.  THE LUNG VOLUME AND ITS SUBDIVISIONS: I. METHODS OF MEASUREMENT.

Authors:  R V Christie
Journal:  J Clin Invest       Date:  1932-11       Impact factor: 14.808
  2 in total
  5 in total

1.  A method for the determination of the volume of air in the lungs: measurements in chronic pulmonary emphysema.

Authors:  G EMMANUEL; W A BRISCOE; A COURNAND
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

2.  [Interferometric determination of residual air volume of the lung by nitrogen serial method in closed circulatory system].

Authors:  F SPENGLER
Journal:  Klin Wochenschr       Date:  1957-06-15

3.  STUDIES ON THE INTRAPULMONARY MIXTURE OF GASES. II. ANALYSIS OF THE REBREATHING METHOD (CLOSED CIRCUIT) FOR MEASURING RESIDUAL AIR.

Authors:  A Cournand; R C Darling; J S Mansfield; D W Richards
Journal:  J Clin Invest       Date:  1940-07       Impact factor: 14.808

4.  THE VOLUME OF THE LUNG DETERMINED BY HELIUM DILUTION. DESCRIPTION OF THE METHOD AND COMPARISON WITH OTHER PROCEDURES.

Authors:  G R Meneely; N L Kaltreider
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

5.  History of right heart catheterization: 100 years of experimentation and methodology development.

Authors:  Bobby D Nossaman; Brittni A Scruggs; Vaughn E Nossaman; Subramanyam N Murthy; Philip J Kadowitz
Journal:  Cardiol Rev       Date:  2010 Mar-Apr       Impact factor: 2.644
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.